Tonix Pharmaceuticals (TNXP) Revenue & Revenue Breakdown
Tonix Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$10.09M
Latest Revenue (Q)
$2.82M
Tonix Pharmaceuticals Revenue by Period
Tonix Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $10.09M | 29.94% |
2023-12-31 | $7.77M | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2008-12-31 | - | - |
Tonix Pharmaceuticals generated $10.09M in revenue during NA 2024, up 29.94% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Tonix Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $2.82M | 27.81% |
2024-06-30 | $2.21M | -11.04% |
2024-03-31 | $2.48M | -34.32% |
2023-12-31 | $3.78M | -5.26% |
2023-09-30 | $3.99M | 100.00% |
2023-06-30 | - | -100.00% |
2023-03-31 | $33.90M | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | -100.00% |
2022-06-30 | $9.03M | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | -100.00% |
2020-12-31 | $2.91M | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | -100.00% |
2019-12-31 | $-500.00 | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2012-09-30 | - | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2011-09-30 | - | 100.00% |
2011-06-30 | - | 100.00% |
2011-03-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2010-09-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2010-03-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2009-09-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2008-09-30 | - | 100.00% |
2008-06-30 | - | 100.00% |
2008-03-31 | - | - |
Tonix Pharmaceuticals generated $2.82M in revenue during Q3 2024, up 27.81% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Tonix Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
NVAX | Novavax | $682.16M | $415.48M |
VXRT | Vaxart | $28.70M | $4.93M |
JAGX | Jaguar Health | $11.56M | $3.07M |
TNXP | Tonix Pharmaceuticals | $10.09M | $2.82M |
SONN | Sonnet BioTherapeutics | $147.81K | $1.00M |
VRAX | Virax Biolabs Group | $8.56K | $76.50K |
INO | Inovio Pharmaceuticals | - | - |
ENVB | Enveric Biosciences | - | - |
PALI | Palisade Bio | - | - |
DRUG | Bright Minds Biosciences | - | - |